 | • レポートコード：MRC23Q33348 • 出版社/出版日：QYResearch / 2023年3月 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール（2-3日） • 産業分類：化学＆材料 |
| Single User | ￥435,000 (USD2,900) | ▷ お問い合わせ |
| Enterprise License | ￥870,000 (USD5,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは世界のメサラジンAPI市場について調査・分析し、世界のメサラジンAPI市場概要、メーカー別競争状況、地域別生産量、地域別消費量、タイプ別セグメント分析（97%以上、98%以上、99%以上）、用途別セグメント分析（錠剤、カプセル剤、顆粒剤、坐剤、浣腸剤、その他）、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、PharmaZell、Syntese A/S、Cambrex Corporation、Divis Laboratories、Chemi SpA、Ipca Laboratories、Hangzhou Brother、Lianyungang Fengheng Biopharm、Lasa Loboratory、Corden Pharma Bergamo、Erregierre SpA、CTX Lifescience、Ishita Active Pharma Ingredients、YC Biotech (Jiangsu)、Xinxiang Tianfeng Fine Chemicalなどが含まれています。 世界のメサラジンAPI市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間中の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争による影響は、メサラジンAPI市場規模を推定する際に考慮しました。本レポートは、メサラジンAPIの世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を把握し、現在の市場における自社のポジションを分析し、メサラジンAPIに関するビジネス上の意思決定に役立てることを目的としています。 ・メサラジンAPI市場の概要 - 製品の定義 - メサラジンAPIのタイプ別セグメント - 世界のメサラジンAPI市場成長率のタイプ別分析（97%以上、98%以上、99%以上） - メサラジンAPIの用途別セグメント - 世界のメサラジンAPI市場成長率の用途別分析（錠剤、カプセル剤、顆粒剤、坐剤、浣腸剤、その他） - 世界市場の成長展望 - 世界のメサラジンAPI生産量の推定と予測（2018年-2029年） - 世界のメサラジンAPI生産能力の推定と予測（2018年-2029年） - メサラジンAPIの平均価格の推定と予測（2018年-2029年） - 前提条件と制限事項 ・メーカー別競争状況 - メーカー別市場シェア - 世界の主要メーカー、業界ランキング分析 - メーカー別平均価格 - メサラジンAPI市場の競争状況およびトレンド ・メサラジンAPIの地域別生産量 - メサラジンAPI生産量の地域別推計と予測（2018年-2029年） - 地域別メサラジンAPI価格分析（2018年-2023年） - 北米のメサラジンAPI生産規模（2018年-2029年） - ヨーロッパのメサラジンAPI生産規模（2018年-2029年） - 中国のメサラジンAPI生産規模（2018年-2029年） - 日本のメサラジンAPI生産規模（2018年-2029年） - 韓国のメサラジンAPI生産規模（2018年-2029年） - インドのメサラジンAPI生産規模（2018年-2029年） ・メサラジンAPIの地域別消費量 - メサラジンAPI消費量の地域別推計と予測（2018年-2029年） - 北米のメサラジンAPI消費量（2018年-2029年） - アメリカのメサラジンAPI消費量（2018年-2029年） - ヨーロッパのメサラジンAPI消費量（2018年-2029年） - アジア太平洋のメサラジンAPI消費量（2018年-2029年） - 中国のメサラジンAPI消費量（2018年-2029年） - 日本のメサラジンAPI消費量（2018年-2029年） - 韓国のメサラジンAPI消費量（2018年-2029年） - 東南アジアのメサラジンAPI消費量（2018年-2029年） - インドのメサラジンAPI消費量（2018年-2029年） - 中南米・中東・アフリカのメサラジンAPI消費量（2018年-2029年） ・タイプ別セグメント：97%以上、98%以上、99%以上 - 世界のメサラジンAPIのタイプ別生産量（2018年-2023年） - 世界のメサラジンAPIのタイプ別生産量（2024年-2029年） - 世界のメサラジンAPIのタイプ別価格 ・用途別セグメント：錠剤、カプセル剤、顆粒剤、坐剤、浣腸剤、その他 - 世界のメサラジンAPIの用途別生産量（2018年-2023年） - 世界のメサラジンAPIの用途別生産量（2024年-2029年） - 世界のメサラジンAPIの用途別価格 ・主要企業のプロファイル：企業情報、製品ポートフォリオ、生産量、価格、動向 PharmaZell、Syntese A/S、Cambrex Corporation、Divis Laboratories、Chemi SpA、Ipca Laboratories、Hangzhou Brother、Lianyungang Fengheng Biopharm、Lasa Loboratory、Corden Pharma Bergamo、Erregierre SpA、CTX Lifescience、Ishita Active Pharma Ingredients、YC Biotech (Jiangsu)、Xinxiang Tianfeng Fine Chemical ・産業チェーンと販売チャネルの分析 - メサラジンAPI産業チェーン分析 - メサラジンAPIの主要原材料 - メサラジンAPIの販売チャネル - メサラジンAPIのディストリビューター - メサラジンAPIの主要顧客 ・メサラジンAPI市場ダイナミクス - メサラジンAPIの業界動向 - メサラジンAPI市場の成長ドライバ、課題、阻害要因 ・調査成果および結論 ・調査方法とデータソース |
The global Mesalazine API market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Mesalazine API is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Mesalazine API is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Mesalazine API include PharmaZell, Syntese A/S, Cambrex Corporation, Divis Laboratories, Chemi SpA, Ipca Laboratories, Hangzhou Brother, Lianyungang Fengheng Biopharm and Lasa Loboratory, etc. In 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Mesalazine API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Mesalazine API.
The Mesalazine API market size, estimations, and forecasts are provided in terms of output/shipments (Tons) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Mesalazine API market comprehensively. Regional market sizes, concerning products by purity, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Mesalazine API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by purity, by application, and by regions.
By Company
PharmaZell
Syntese A/S
Cambrex Corporation
Divis Laboratories
Chemi SpA
Ipca Laboratories
Hangzhou Brother
Lianyungang Fengheng Biopharm
Lasa Loboratory
Corden Pharma Bergamo
Erregierre SpA
CTX Lifescience
Ishita Active Pharma Ingredients
YC Biotech (Jiangsu)
Xinxiang Tianfeng Fine Chemical
Segment by Purity
Above 97 %
Above 98 %
Above 99 %
Segment by Application
Tablets
Capsules
Granule
Suppository
Enema
Others
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by purity, by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Mesalazine API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Mesalazine API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Mesalazine API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by purity, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
1 Mesalazine API Market Overview
1.1 Product Definition
1.2 Mesalazine API Segment by Purity
1.2.1 Global Mesalazine API Market Value Growth Rate Analysis by Purity 2022 VS 2029
1.2.2 Above 97 %
1.2.3 Above 98 %
1.2.4 Above 99 %
1.3 Mesalazine API Segment by Application
1.3.1 Global Mesalazine API Market Value Growth Rate Analysis by Application: 2022 VS 2029
1.3.2 Tablets
1.3.3 Capsules
1.3.4 Granule
1.3.5 Suppository
1.3.6 Enema
1.3.7 Others
1.4 Global Market Growth Prospects
1.4.1 Global Mesalazine API Production Value Estimates and Forecasts (2018-2029)
1.4.2 Global Mesalazine API Production Capacity Estimates and Forecasts (2018-2029)
1.4.3 Global Mesalazine API Production Estimates and Forecasts (2018-2029)
1.4.4 Global Mesalazine API Market Average Price Estimates and Forecasts (2018-2029)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Mesalazine API Production Market Share by Manufacturers (2018-2023)
2.2 Global Mesalazine API Production Value Market Share by Manufacturers (2018-2023)
2.3 Global Key Players of Mesalazine API, Industry Ranking, 2021 VS 2022 VS 2023
2.4 Global Mesalazine API Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global Mesalazine API Average Price by Manufacturers (2018-2023)
2.6 Global Key Manufacturers of Mesalazine API, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Mesalazine API, Product Offered and Application
2.8 Global Key Manufacturers of Mesalazine API, Date of Enter into This Industry
2.9 Mesalazine API Market Competitive Situation and Trends
2.9.1 Mesalazine API Market Concentration Rate
2.9.2 Global 5 and 10 Largest Mesalazine API Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Mesalazine API Production by Region
3.1 Global Mesalazine API Production Value Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
3.2 Global Mesalazine API Production Value by Region (2018-2029)
3.2.1 Global Mesalazine API Production Value Market Share by Region (2018-2023)
3.2.2 Global Forecasted Production Value of Mesalazine API by Region (2024-2029)
3.3 Global Mesalazine API Production Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
3.4 Global Mesalazine API Production by Region (2018-2029)
3.4.1 Global Mesalazine API Production Market Share by Region (2018-2023)
3.4.2 Global Forecasted Production of Mesalazine API by Region (2024-2029)
3.5 Global Mesalazine API Market Price Analysis by Region (2018-2023)
3.6 Global Mesalazine API Production and Value, Year-over-Year Growth
3.6.1 North America Mesalazine API Production Value Estimates and Forecasts (2018-2029)
3.6.2 Europe Mesalazine API Production Value Estimates and Forecasts (2018-2029)
3.6.3 China Mesalazine API Production Value Estimates and Forecasts (2018-2029)
3.6.4 Japan Mesalazine API Production Value Estimates and Forecasts (2018-2029)
4 Mesalazine API Consumption by Region
4.1 Global Mesalazine API Consumption Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
4.2 Global Mesalazine API Consumption by Region (2018-2029)
4.2.1 Global Mesalazine API Consumption by Region (2018-2023)
4.2.2 Global Mesalazine API Forecasted Consumption by Region (2024-2029)
4.3 North America
4.3.1 North America Mesalazine API Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.3.2 North America Mesalazine API Consumption by Country (2018-2029)
4.3.3 United States
4.3.4 Canada
4.4 Europe
4.4.1 Europe Mesalazine API Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.4.2 Europe Mesalazine API Consumption by Country (2018-2029)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Mesalazine API Consumption Growth Rate by Region: 2018 VS 2022 VS 2029
4.5.2 Asia Pacific Mesalazine API Consumption by Region (2018-2029)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Mesalazine API Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.6.2 Latin America, Middle East & Africa Mesalazine API Consumption by Country (2018-2029)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
5 Segment by Purity
5.1 Global Mesalazine API Production by Purity (2018-2029)
5.1.1 Global Mesalazine API Production by Purity (2018-2023)
5.1.2 Global Mesalazine API Production by Purity (2024-2029)
5.1.3 Global Mesalazine API Production Market Share by Purity (2018-2029)
5.2 Global Mesalazine API Production Value by Purity (2018-2029)
5.2.1 Global Mesalazine API Production Value by Purity (2018-2023)
5.2.2 Global Mesalazine API Production Value by Purity (2024-2029)
5.2.3 Global Mesalazine API Production Value Market Share by Purity (2018-2029)
5.3 Global Mesalazine API Price by Purity (2018-2029)
6 Segment by Application
6.1 Global Mesalazine API Production by Application (2018-2029)
6.1.1 Global Mesalazine API Production by Application (2018-2023)
6.1.2 Global Mesalazine API Production by Application (2024-2029)
6.1.3 Global Mesalazine API Production Market Share by Application (2018-2029)
6.2 Global Mesalazine API Production Value by Application (2018-2029)
6.2.1 Global Mesalazine API Production Value by Application (2018-2023)
6.2.2 Global Mesalazine API Production Value by Application (2024-2029)
6.2.3 Global Mesalazine API Production Value Market Share by Application (2018-2029)
6.3 Global Mesalazine API Price by Application (2018-2029)
7 Key Companies Profiled
7.1 PharmaZell
7.1.1 PharmaZell Mesalazine API Corporation Information
7.1.2 PharmaZell Mesalazine API Product Portfolio
7.1.3 PharmaZell Mesalazine API Production, Value, Price and Gross Margin (2018-2023)
7.1.4 PharmaZell Main Business and Markets Served
7.1.5 PharmaZell Recent Developments/Updates
7.2 Syntese A/S
7.2.1 Syntese A/S Mesalazine API Corporation Information
7.2.2 Syntese A/S Mesalazine API Product Portfolio
7.2.3 Syntese A/S Mesalazine API Production, Value, Price and Gross Margin (2018-2023)
7.2.4 Syntese A/S Main Business and Markets Served
7.2.5 Syntese A/S Recent Developments/Updates
7.3 Cambrex Corporation
7.3.1 Cambrex Corporation Mesalazine API Corporation Information
7.3.2 Cambrex Corporation Mesalazine API Product Portfolio
7.3.3 Cambrex Corporation Mesalazine API Production, Value, Price and Gross Margin (2018-2023)
7.3.4 Cambrex Corporation Main Business and Markets Served
7.3.5 Cambrex Corporation Recent Developments/Updates
7.4 Divis Laboratories
7.4.1 Divis Laboratories Mesalazine API Corporation Information
7.4.2 Divis Laboratories Mesalazine API Product Portfolio
7.4.3 Divis Laboratories Mesalazine API Production, Value, Price and Gross Margin (2018-2023)
7.4.4 Divis Laboratories Main Business and Markets Served
7.4.5 Divis Laboratories Recent Developments/Updates
7.5 Chemi SpA
7.5.1 Chemi SpA Mesalazine API Corporation Information
7.5.2 Chemi SpA Mesalazine API Product Portfolio
7.5.3 Chemi SpA Mesalazine API Production, Value, Price and Gross Margin (2018-2023)
7.5.4 Chemi SpA Main Business and Markets Served
7.5.5 Chemi SpA Recent Developments/Updates
7.6 Ipca Laboratories
7.6.1 Ipca Laboratories Mesalazine API Corporation Information
7.6.2 Ipca Laboratories Mesalazine API Product Portfolio
7.6.3 Ipca Laboratories Mesalazine API Production, Value, Price and Gross Margin (2018-2023)
7.6.4 Ipca Laboratories Main Business and Markets Served
7.6.5 Ipca Laboratories Recent Developments/Updates
7.7 Hangzhou Brother
7.7.1 Hangzhou Brother Mesalazine API Corporation Information
7.7.2 Hangzhou Brother Mesalazine API Product Portfolio
7.7.3 Hangzhou Brother Mesalazine API Production, Value, Price and Gross Margin (2018-2023)
7.7.4 Hangzhou Brother Main Business and Markets Served
7.7.5 Hangzhou Brother Recent Developments/Updates
7.8 Lianyungang Fengheng Biopharm
7.8.1 Lianyungang Fengheng Biopharm Mesalazine API Corporation Information
7.8.2 Lianyungang Fengheng Biopharm Mesalazine API Product Portfolio
7.8.3 Lianyungang Fengheng Biopharm Mesalazine API Production, Value, Price and Gross Margin (2018-2023)
7.8.4 Lianyungang Fengheng Biopharm Main Business and Markets Served
7.7.5 Lianyungang Fengheng Biopharm Recent Developments/Updates
7.9 Lasa Loboratory
7.9.1 Lasa Loboratory Mesalazine API Corporation Information
7.9.2 Lasa Loboratory Mesalazine API Product Portfolio
7.9.3 Lasa Loboratory Mesalazine API Production, Value, Price and Gross Margin (2018-2023)
7.9.4 Lasa Loboratory Main Business and Markets Served
7.9.5 Lasa Loboratory Recent Developments/Updates
7.10 Corden Pharma Bergamo
7.10.1 Corden Pharma Bergamo Mesalazine API Corporation Information
7.10.2 Corden Pharma Bergamo Mesalazine API Product Portfolio
7.10.3 Corden Pharma Bergamo Mesalazine API Production, Value, Price and Gross Margin (2018-2023)
7.10.4 Corden Pharma Bergamo Main Business and Markets Served
7.10.5 Corden Pharma Bergamo Recent Developments/Updates
7.11 Erregierre SpA
7.11.1 Erregierre SpA Mesalazine API Corporation Information
7.11.2 Erregierre SpA Mesalazine API Product Portfolio
7.11.3 Erregierre SpA Mesalazine API Production, Value, Price and Gross Margin (2018-2023)
7.11.4 Erregierre SpA Main Business and Markets Served
7.11.5 Erregierre SpA Recent Developments/Updates
7.12 CTX Lifescience
7.12.1 CTX Lifescience Mesalazine API Corporation Information
7.12.2 CTX Lifescience Mesalazine API Product Portfolio
7.12.3 CTX Lifescience Mesalazine API Production, Value, Price and Gross Margin (2018-2023)
7.12.4 CTX Lifescience Main Business and Markets Served
7.12.5 CTX Lifescience Recent Developments/Updates
7.13 Ishita Active Pharma Ingredients
7.13.1 Ishita Active Pharma Ingredients Mesalazine API Corporation Information
7.13.2 Ishita Active Pharma Ingredients Mesalazine API Product Portfolio
7.13.3 Ishita Active Pharma Ingredients Mesalazine API Production, Value, Price and Gross Margin (2018-2023)
7.13.4 Ishita Active Pharma Ingredients Main Business and Markets Served
7.13.5 Ishita Active Pharma Ingredients Recent Developments/Updates
7.14 YC Biotech (Jiangsu)
7.14.1 YC Biotech (Jiangsu) Mesalazine API Corporation Information
7.14.2 YC Biotech (Jiangsu) Mesalazine API Product Portfolio
7.14.3 YC Biotech (Jiangsu) Mesalazine API Production, Value, Price and Gross Margin (2018-2023)
7.14.4 YC Biotech (Jiangsu) Main Business and Markets Served
7.14.5 YC Biotech (Jiangsu) Recent Developments/Updates
7.15 Xinxiang Tianfeng Fine Chemical
7.15.1 Xinxiang Tianfeng Fine Chemical Mesalazine API Corporation Information
7.15.2 Xinxiang Tianfeng Fine Chemical Mesalazine API Product Portfolio
7.15.3 Xinxiang Tianfeng Fine Chemical Mesalazine API Production, Value, Price and Gross Margin (2018-2023)
7.15.4 Xinxiang Tianfeng Fine Chemical Main Business and Markets Served
7.15.5 Xinxiang Tianfeng Fine Chemical Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Mesalazine API Industry Chain Analysis
8.2 Mesalazine API Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Mesalazine API Production Mode & Process
8.4 Mesalazine API Sales and Marketing
8.4.1 Mesalazine API Sales Channels
8.4.2 Mesalazine API Distributors
8.5 Mesalazine API Customers
9 Mesalazine API Market Dynamics
9.1 Mesalazine API Industry Trends
9.2 Mesalazine API Market Drivers
9.3 Mesalazine API Market Challenges
9.4 Mesalazine API Market Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer